Fig. 3From: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabineVenn diagram and changes of the four overlapping genes in three cell lines treated with decitabine (IC50 of decitabine: Kasumi-1 < THP-1 < MV4-11). A Venn diagram. B The methylation density (β) of the 4 genes before treatment. C The changes of methylation density (Δβ) of the 4 genes after treatment with decitabine. D The mRNA (FPKM) of the 4 genes before treatment. E The changes of mRNA (log2FC) of the 4 genes after treatment with decitabineBack to article page